SAB Biotherapeutics, Inc.

Q4 2023 13F Holders

Symbol
SABS
CUSIP
78397T202
Type
Equity
Class
COM NEW
Num filings
3
Total reported value, excl. options
$6.06 M
Manager Report Date Value ($000) Shares Option Type